Optimizing clinical trial site performance: A focus on three AI capabilities
IBM Business Partners
AUGUST 7, 2023
The inability to meet planned recruitment timelines and the failure of certain sites to enroll participants contribute to a substantial monetary impact for pharmaceutical companies that may be relayed to providers and patients in the form of higher costs for medicines and healthcare services. Department of Health and Human Services.
Let's personalize your content